Patrick v. Comm'r

142 T.C. No. 5, 142 T.C. 124, 2014 U.S. Tax Ct. LEXIS 5
CourtUnited States Tax Court
DecidedFebruary 24, 2014
DocketDocket No. 16387-12.
StatusPublished
Cited by2 cases

This text of 142 T.C. No. 5 (Patrick v. Comm'r) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Patrick v. Comm'r, 142 T.C. No. 5, 142 T.C. 124, 2014 U.S. Tax Ct. LEXIS 5 (tax 2014).

Opinion

OPINION

KROUPA, Judge:

Respondent determined deficiencies of $716,8831 and $94,714 in petitioners’ Federal income tax for 2008 and 2009, respectively (years at issue). We must decide whether a qui tam award qualifies for capital gains treatment under section 1222.2 We hold that a qui tam award does not satisfy the capital gains requirements.

Background

The parties submitted this case fully stipulated pursuant to Rule 122, and the facts are so found. The stipulation of facts and its accompanying exhibits are incorporated by this reference. Petitioners resided in Wisconsin when they filed the petition.

Petitioner husband served as a reimbursement manager for Kyphon, Inc. (Kyphon). Kyphon designed, manufactured and marketed minimally invasive equipment to treat certain spinal conditions. The equipment allowed for treatment by outpatient procedure. Kyphon feared that medical providers would avoid purchasing the equipment because performing the procedure on an outpatient basis would no longer generate revenue from overnight hospital stays. Kyphon therefore instructed its sales representatives to market the procedure as inpatient. Certain medical providers that purchased the equipment had patients admitted when undergoing the treatment. Some medical providers billed this expense to the Government under Medicare.

Petitioner husband and another Kyphon employee, Charles Bates, believed that Kyphon’s practices violated Federal law. Petitioner husband and Mr. Bates agreed to file a qui tarn complaint and to split any relator’s award. Petitioner husband had collected various documents he had helped create during his employment that demonstrated Kyphon’s practices. Petitioner husband also kept some internal Kyphon documents and external marketing material.

Petitioner husband and Mr. Bates filed a qui tarn complaint alleging Kyphon had defrauded the Government. Kyphon eventually settled the matter for $75 million. The Government intervened after Kyphon agreed to the settlement.

Petitioner husband and Mr. Bates then filed additional qui tarn complaints against various medical providers. Those entities also entered into cash settlements to resolve the complaints.

Petitioner husband received a relator’s share of $5,979,282 in 2008 and $856,123 in 2009. The Government issued to petitioner Forms 1099-MISC, Miscellaneous Income, for the years at issue reflecting those amounts.

Petitioners jointly filed Forms 1040, U.S. Individual Income Tax Return, for the years at issue. Petitioners reported the awards (less attorney’s fees) as capital gains. Respondent issued petitioners a deficiency notice that disallowed capital gains treatment for the awards and characterized the amounts as other income. Petitioners timely filed a petition challenging respondent’s determinations.

Discussion

We are asked to decide whether a qui tam relator’s share award is entitled to capital gains treatment. Petitioners argue that petitioner husband sold information to the Government in exchange for a share of any recovery. Respondent, on the other hand, argues that the relator’s share is similar to a reward and does not satisfy the requirements for capital gains treatment. We will consider qui tam actions and the requirements for capital gains treatment.3

I. Qui Tam and the False Claims Act

We begin with a qui tam action. The phrase “qui tam” is short for a Latin phrase4 meaning one “who pursues this action on our Lord the King’s behalf as well as his own.” See Vt. Agency of Natural Res. v. United States ex rel. Stevens, 529 U.S. 765, 768 n.1 (2000). Congress has enacted multiple qui tam provisions, including the False Claims Act (FCA), 31 U.S.C. secs. 3729-3733, in 1863. Id. at 768-769. The FCA imposes civil liability on any person who knowingly presents a false or fraudulent claim for payment or approval. 31 U.S.C. sec. 3729(a) (2006).

The FCA authorizes a person, referred to as the relator, to file under seal a complaint seeking reimbursement on the Government’s behalf. Id. sec. 3730(b)(1). The relator must serve on the Government the complaint and all supporting information the relator possesses before the action may proceed. Id. sec. 3730(b)(2). The Government may intervene and prosecute the matter. Id. sec. 3730(c)(1), (d)(4). The Government may request dismissal or settle the action with the court’s approval. Id. sec. 3730(c)(2)(A) and (B). Further, the Government may seek to limit the relator’s participation in the litigation. Id. sec. 3730(c)(2)(C). The relator is responsible for litigating the matter if the Government does not intervene. Id. sec. 3730(b)(4)(B).

If the Government prosecutes the complaint, then the court shall award a relator between 15% and 25% of any amount recovered. Id. sec. 3730(d)(1). The court shall award a relator between 25% and 30% of any amount recovered when the Government does not intervene. Id. sec. 3730(d)(2). The court may decrease the award if the relator relied primarily on publicly available information or choose to award nothing if the relator planned or participated in the underlying conduct. Id. sec. 3730(d)(1), (3).

II. Whether a Qui Tam Award Is a Capital Gain

We now consider whether a qui tarn award is a capital gain. Petitioners argue that their qui tarn awards are entitled to capital gains treatment. A capital gain is a “gain from the sale or exchange of a capital asset.” Sec. 1222(1), (3). Petitioners consequently must demonstrate that a qui tarn award resulted from a “sale or exchange” of a “capital asset” as those terms are intended. Petitioners theorize that the FCA forms a contract under which the relator sells information to the Government in exchange for a share of the recovery. See United States ex rel. Russell v. Epic Healthcare Mgmt. Grp., 193 F.3d 304, 309 (5th Cir. 1999). Respondent disputes that there was a sale or exchange or that petitioners held a capital asset. We agree with respondent. We address each requirement in turn.

A. Sale or Exchange Requirement

We first consider whether petitioners received the qui tarn awards through a transaction considered to be a sale or exchange. See sec. 1222. Petitioners argue that a relator sells his information to the Government. Respondent contends that the relator’s statutory obligation to provide all supporting information does not constitute a sale or exchange. We agree with respondent.

Transactions involving the transfer of capital assets must be “in the nature of a sale” to qualify for capital gains treatment. Freda v. Commissioner, 656 F.3d 570, 577 (7th Cir. 2011), aff’g T.C. Memo. 2009-191. We have applied the ordinary meaning of the phrase “sale or exchange” because it is not defined in the Code. Nahey v. Commissioner, 111 T.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Craig Patrick & Michele Patrick v. Commissioner
142 T.C. No. 5 (U.S. Tax Court, 2014)
Patrick v. Comm'r
142 T.C. No. 5 (U.S. Tax Court, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
142 T.C. No. 5, 142 T.C. 124, 2014 U.S. Tax Ct. LEXIS 5, Counsel Stack Legal Research, https://law.counselstack.com/opinion/patrick-v-commr-tax-2014.